Abstract:The binding stoichiometry between Cu(II) and the full-length beta-amyloid A beta(l -42) and the oxidation state of copper in the resultant complex were determined by electrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry (ESI-FTICR-MS) and cyclic voltammetry. The same approach was extended to the copper complexes of A beta(1-16) and A beta(1-28). A stoichiometric ratio of 1:1 was directly observed, and the oxidation state of copper was deduced to be 2+ for all of the complexes, and residues tyrosine-10 and methionine-35 are not oxidized in the A beta(1-42)-Cu(II) complex. The stoichiometric ratio remains the same in the presence of more than a 10-fold excess of Cu(II). Redox potentials of the sole tyrosine residue and the Cu(II) center were determined to be ca. 0.75 and 0.08 V vs Ag/AgCl [or 0.95 and 0.28 V vs normal hydrogen electrode (NHE)], respectively. More importantly, for the first time, the A beta-Cu(I) complex has been generated electrochemically and was found to catalyze the reduction of oxygen to produce hydrogen peroxide. The voltammetric behaviors of the three A beta segments suggest that diffusion of oxygen to the metal center can be affected by the length and hydrophobicity of the A beta peptide. The determination and assignment of the redox potentials clarify some misconceptions in the redox reactions involving A beta and provide new insight into the possible roles of redox metal ions in the Alzheimer's disease (AD) pathogenesis. In cellular environments, the reduction potential of the A beta-Cu(II) complex is sufficiently high to react with antioxidants (e.g., ascorbic acid) and cellular redox buffers (e.g., glutathione), and the A beta-Cu(I) complex produced could subsequently reduce oxygen to form hydrogen peroxide via a catalytic cycle. Using voltammetry, the A beta-Cu(II) complex formed in solution was found to be readily reduced by ascorbic acid. Hydrogen peroxide produced, in addition to its role in damaging DNA, protein, and lipid molecules, can also be involved in the further consumption of antioxidants, causing their depletion in neurons and eventually damaging the neuronal defense system. Another possibility is that A beta-Cu(II) could react with species involved in the cascade of electron transfer events of mitochondria and might potentially sidetrack the electron transfer processes in the respiratory chain, leading to mitochondrial dysfunction.

Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro

Cu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structure

Redox Reactions Of Copper Complexes Formed With Different Beta-Amyloid Peptides And Their Neuropathalogical Relevance

The Double-Edged Role of Copper in the Fate of Amyloid Beta in the Presence of Anti-Oxidants.

Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical Relevance<sup>†</sup>

Amyloid-β Peptide （1-42） Aggregation Induced by Copper Ions under Acidic Conditions

Copper inducing Aβ42 rather than Aβ40 nanoscale oligomer formation is the key process for Aβ neurotoxicity.

Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity

Cu2+ Affects Amyloid-\b{eta} (1-42) Aggregation by Increasing Peptide-Peptide Binding Forces

Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.

Amyloid- Peptide (142) Aggregation Induced By Copper Ions Under Acidic Conditions

Molecular Modeling of the Inhibitory Mechanism of Copper(ii) on Aggregation of Amyloid Β-Peptide

Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.

Copper catalyzed oxidation of alzheimer A beta

pH-dependent kinetics of copper ions binding to amyloid-β peptide.

The co-effect of copper and lipid vesicles on Aβ aggregation.

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar-Affinity Copper Binding Site on Amyloid β1-42

Redox behaviour of Cu-Aβ(4-16) complexes related to Alzheimer's Disease

Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron